Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 1
Journal homepage
38
Views
22
CrossRef citations to date
0
Altmetric
CASE REPORT

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis

Motohisa YamamotoFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, JapanCorrespondence[email protected]
,
Hiroki TakahashiFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Hideki WakasugiFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Yasutaka SukawaFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Mayuko SaitoFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Chisako SuzukiFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Yasuyoshi NaishiroFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Hiroyuki YamamotoFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
,
Yasuhisa ShinomuraFirst Department of Internal Medicine, Sapporo Medical University, School of Medicine,South 1-West 16, Chuo-ku, Sapporo 060-8543, Japan
&
Kohzoh ImaiSapporo Medical University,Sapporo, Japan
 show all
Pages 72-74 | Received 15 Jun 2006, Accepted 10 Oct 2006, Published online: 02 Jan 2014

References

  • Guidelines for the proper use of anti-TNF drugs against rheumatoid arthritis. Japanese College of Rheumatology. http://www. ryumachi-jp.com/Ryumachi/Secure/kaiin/medical/brm_guideline. html
  • Imperato AK, Bingham CO III, Abramson SB. Overview of benefi t/risk of biological agents. Clin Exp Rheumatol 2004;22(Suppl 35):S108–14.
  • Roos JC, Ostor AJ. Anti-tumor necrosis factor alpha therapy and the risk of JC virus infection. Arthritis Rheum 2006;54:381–2.
  • Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81: 93–111.
  • Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971;1(7712):1257–69.
  • Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepideminology of the human polyomaviruses. J Gen Virol 2003;84:1499–504.
  • Kimura A, Ueyama H, Kimura N, Fujimoto S, Kumamoto T. Progressive multifocal leukoencephalopathy in an HTLV-1 carrier. Clin Neurol Neurosurg 2005 Oct 26; [Epub ahead of print]
  • Ahmed F, Aziz T, Kaufman LD. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. J Rheumatol 1999;26:1609–12.
  • Subsai K, Kanoksri S, Siwaporn C, Helen L, Kanokporn O, Wantana P. Neurological complications in AIDS patients receiving HAART: a 2-year retrospective study. Eur J Neurol 2006;13: 233–9.
  • Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003;9(Suppl 1):47–53.
  • Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004;17:365–70.
  • Van Assche G, van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005;353: 362–8.
  • Kleinschmiedt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon �-1a for multiple sclerosis. N Engl J Med 2005;353: 369–74.
  • Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005;353:375–81.
  • Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006;354:924–33.
  • Ransohoff RM. Natalizumab and PML. Nat Neurosci 2005;8:1275.
  • Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al. Demyelination occurring during anti-tumor necrosis factor � therapy for infl ammatory arthritides. Arthritis Rheum 2001;44:2862–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.